De Corte V, Gettemans J, Waelkens E, Vandekerckhove J
Flanders Interuniversity Institute of Biotechnology, Department of Biochemistry, Universiteit Gent, Belgium.
Eur J Biochem. 1996 Nov 1;241(3):901-8. doi: 10.1111/j.1432-1033.1996.00901.x.
Actin-fragmin is a heterodimeric protein complex from Physarum polycephalum microplasmodia that is phosphorylated in vitro at residues Thr203 and Thr202 of the actin subunit by the endogenous actin-fragmin kinase. Following phosphorylation, the F-actin capping activity of the complex becomes Ca(2+)-dependent, suggesting a fundamental regulatory role in controlling F-actin growth [Gettemans, J., De Ville, Y., Waelkens E. and Vandekerckhove, J. (1995) J. Biol. Chem. 270, 2644-2651]. In this study we analysed actin phosphorylation in vivo. We demonstrate that the actin-fragmin complex constitutes the only substrate of the actin-fragmin kinase in plasmodia. Monomeric actin is not phosphorylated. Immunoprecipitation of actin-fragmin reveals that approximately 40% of the actin subunit of the complex is phosphorylated in vivo. However, using purified substrate and kinase, the complex can be quantitatively phosphorylated as judged by two-dimensional gel electrophoresis. Through comparative phosphopeptide fingerprinting, we show that the phosphorylation sites in vivo are identical to those identified in vitro. We additionally characterized a complex of actin and the NH2-terminal half of fragmin (residues 1-168) that is also phosphorylated by the same kinase. In contrast to actin-fragmin, phosphorylation of the complex between actin and residues 1-168 of fragmin is independent of Ca2+ because the second Ca(2+)-dependent regulatory actin-binding domain is missing. By artificially varying the actin-fragmin concentration or the actin-fragmin kinase activity present in microplasmodia cytosolic extracts, we attempted to detect alternative protein substrates for the actin-fragmin kinase. The fact that none could be identified suggests that the control and properties of actin-fragmin phosphorylation observed in vitro may stand as a model for F-actin growth control in Physarum cells.
肌动蛋白 - 凝溶胶蛋白是一种来自多头绒泡菌微原质团的异源二聚体蛋白复合物,其肌动蛋白亚基的苏氨酸203和苏氨酸202残基在体外被内源性肌动蛋白 - 凝溶胶蛋白激酶磷酸化。磷酸化后,该复合物的F - 肌动蛋白封端活性变为Ca(2 +)依赖性,这表明其在控制F - 肌动蛋白生长中具有重要的调节作用[Gettemans, J., De Ville, Y., Waelkens E.和Vandekerckhove, J. (1995) J. Biol. Chem. 270, 2644 - 2651]。在本研究中,我们分析了体内的肌动蛋白磷酸化情况。我们证明,肌动蛋白 - 凝溶胶蛋白复合物是原质团中肌动蛋白 - 凝溶胶蛋白激酶的唯一底物。单体肌动蛋白不被磷酸化。对肌动蛋白 - 凝溶胶蛋白进行免疫沉淀显示,该复合物中约40%的肌动蛋白亚基在体内被磷酸化。然而,使用纯化的底物和激酶,通过二维凝胶电泳判断,该复合物可被定量磷酸化。通过比较磷酸肽指纹图谱,我们表明体内的磷酸化位点与体外鉴定的位点相同。我们还鉴定了一种肌动蛋白与凝溶胶蛋白NH2末端一半(残基1 - 168)的复合物,它也被同一激酶磷酸化。与肌动蛋白 - 凝溶胶蛋白不同,肌动蛋白与凝溶胶蛋白残基1 - 168之间复合物的磷酸化不依赖于Ca2 +,因为缺少第二个Ca(2 +)依赖性调节肌动蛋白结合结构域。通过人为改变微原质团胞质提取物中肌动蛋白 - 凝溶胶蛋白的浓度或肌动蛋白 - 凝溶胶蛋白激酶的活性,我们试图检测肌动蛋白 - 凝溶胶蛋白激酶的其他蛋白质底物。未发现其他底物这一事实表明,体外观察到的肌动蛋白 - 凝溶胶蛋白磷酸化的调控和特性可能是绒泡菌细胞中F - 肌动蛋白生长控制的一个模型。